정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 478 | Recruiting | Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19 | COVID-19 | Biological: AZD1222 Biological: rAd26-S |
Phase 2 | R-Pharm, AstraZeneca, Russian Direct Investment Fund, The Gamaleya National Center of Epidemiology & Microbiology | INDUSTRY | 100 | All | 18 Years ~ 130 Years | Vitebsk Regional Clinical Hospital, Vitebsk, Belarus Joint-Stock Company "Group of Companies Medsi", Moscow, Russian Federation OJSC Clinical and Diagnostic Center Euromedservice, Moscow, Russian Federation Research Site, Moscow, Russian Federation LLC PiterClinica, Saint-Petersburg, Russian Federation Federal State Budget Institution "Scientific and Research Institute of Flu n.a. A.A. Smorodintseva" of Ministry of Health of Russian Federation, Saint-Petersburg, Russian Federation Federal State Budgetary Educational Institution of Higher Education " First Saint Petersburg State Medical University named after Academician I. P. Pavlov" of the Ministry of Healthcare of the Russian Federation, St. Petersburg, Russian Federation |
| 477 | Not yet recruiting | Study in Adults to Determine the Safety and Immunogenicity of AZD1222, a Non-replicating ChAdOx1 Vector Vaccine, Given in Combination With rAd26-S, Recombinant Adenovirus Type 26 Component of Gam-COVID-Vac Vaccine, for the Prevention of COVID-19. | COVID-19 | Biological: AZD1222 Biological: rAd26-S |
Phase 2 | R-Pharm, AstraZeneca, Russian Direct Investment Fund, The Gamaleya National Center of Epidemiology & Microbiology | INDUSTRY | 100 | All | 18 Years ~ 100 Years | Baki Saglamic Merkezi, Baku, Azerbaijan |
| 476 | Recruiting | Study in COvid-19 Patients With iveRmectin (CORVETTE-01) | Covid19 | Drug: Ivermectin 3 MG Drug: Placebo |
Phase 2 | Kitasato University | OTHER | 240 | All | 20 Years | Kitasato University, Sagamihara, Kanagawa, Japan |
| 475 | Completed | Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation | COVID-19 | Drug: Remdesivir (RDV) Drug: Placebo |
Phase 2 | Gilead Sciences | INDUSTRY | 156 | All | 18 Years | The Institute for Liver Health, Mesa, Arizona, United States The Institute for Liver Health, Tucson, Arizona, United States Franco Felizarta, MD, Bakersfield, California, United States Aurora FDRC Inc., Costa Mesa, California, United States Elevated Health, Huntington Beach, California, United States Cedars-Sinai Medical Center, Los Angeles, California, United States Western Clinical Research, Placentia, California, United States UC Davis Health/Medical Center, Sacramento, California, United States Bradenton Research Center, Inc., Bradenton, Florida, United States Integrity Clinical Research, LLC, Doral, Florida, United States Holy Cross Hospital, Fort Lauderdale, Florida, United States Evolution Clinical Trials, Inc., Hialeah Gardens, Florida, United States Research in Miami, Inc., Hialeah, Florida, United States Optimus U Corporation, Miami, Florida, United States L & C Professional Medical Research Institute, Miami, Florida, United States Westchester Research Center at Westchester General Hospital, Miami, Florida, United States MedBio Trials, Miami, Florida, United States Nuovida Research Center, Corp, Miami, Florida, United States IMIC Inc, Palmetto Bay, Florida, United States Triple O Research Institute, PA, West Palm Beach, Florida, United States Family Care Research, Boise, Idaho, United States CTU Covid Research Center, New Orleans, Louisiana, United States STAT Research, Vandalia, Ohio, United States Inquest Clinical Research, Baytown, Texas, United States DFW Clinical Research, Dallas, Texas, United States Baylor Research Institute, Dallas, Texas, United States PCP for Life-Tidwell, Houston, Texas, United States Providence Regional Medical Center Everett, Everett, Washington, United States |
| 474 | Recruiting | Study of a Live rNDV Based Vaccine Against COVID-19 | SARS-CoV-2 Infection | Biological: Recombinant NDV Vectored Vaccine for SARS-CoV-2 | Phase 1 | Laboratorio Avi-Mex, S.A. de C.V., National Council of Science and Technology, Mexico, Agencia Mexicana de Cooperacion Internacional para el Desarrollo. AMEXID | INDUSTRY | 90 | All | 18 Years ~ 55 Years | Hospital Medica Sur, Mexico City, Ciudad De Mexico, Mexico |
| 473 | Recruiting | Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine | Influenza (Healthy Volunteers) | Biological: Quadrivalent Inactivated Influenza High Dose Biological: COVID-19 mRNA Vaccine (nucleoside modified) |
Phase 2 | Sanofi Pasteur, a Sanofi Company | INDUSTRY | 300 | All | 65 Years | Investigational Site Number :8400003, Glendale, Arizona, United States Investigational Site Number :8400006, San Diego, California, United States Investigational Site Number :8400004, Vista, California, United States Investigational Site Number :8400005, Centennial, Colorado, United States Investigational Site Number :8400001, Peoria, Illinois, United States Investigational Site Number :8400002, Austin, Texas, United States |
| 472 | Active, not recruiting | Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults | SARS-CoV-2 Infection | Drug: Intramuscular injection Biological: Intramuscular vaccine |
Phase 3 | Medicago | INDUSTRY | 30918 | All | 18 Years | Achieve Clinical Research, LLC dba Accel Research Sites, Birmingham, Alabama, United States Fiel Family and Sports Medicine/CCT, Tempe, Arizona, United States Hope Clinical Research, Canoga Park, California, United States CNS Network, Garden Grove, California, United States Long Beach Clinical Trial Services Inc., Long Beach, California, United States Pharmacology Research Institute, Newport Beach, California, United States Wr-McCr, Llc, San Diego, California, United States Ascension Providence Health System, Washington, District of Columbia, United States Alliance for Multispecialty Research, Coral Gables, Florida, United States Research Centers of America, Hollywood, Florida, United States AppleMed Research Inc, Miami, Florida, United States Elixia COVID-19, Palm Beach, Florida, United States Precision Clinical Research, Sunrise, Florida, United States Meridian Clinical Research, Savannah, Georgia, United States ASR, LLC, Nampa, Idaho, United States Affinity Health, Chicago, Illinois, United States Meridian Clinical Research, Sioux City, Iowa, United States Benchmark Research, Covington, Louisiana, United States Ascension St. John Vaccine Research Unit, Grosse Pointe Woods, Michigan, United States Methodist Physicians, Fremont, Nebraska, United States Be Well Clinical Studies, LLC, Lincoln, Nebraska, United States Meridian Clinical Research LLC, Norfolk, Nebraska, United States Meridian Clinical Research LLC, Omaha, Nebraska, United States Forte Family Practice/ CCT Research, Las Vegas, Nevada, United States Excel Clinical Research, Las Vegas, Nevada, United States Las Vegas Clinical Trials, North Las Vegas, Nevada, United States Hassman Research Institute, Berlin, New Jersey, United States Meridian Clinical Research, Endwell, New York, United States Carolina Institute for Clinical Research, Fayetteville, North Carolina, United States M3 Wake Research, Inc, Raleigh, North Carolina, United States Trial Management Associates LLC, Wilmington, North Carolina, United States Velocity Clinical Research - Cincinnati, Cincinnati, Ohio, United States Velocity Clinical Research, Cleveland, Ohio, United States Aventiv Research Inc, Columbus, Ohio, United States Velocity Clinical Research Providence, Warwick, Rhode Island, United States Benchmark Research, Austin, Texas, United States Tekton Research, Austin, Texas, United States Global Medical Research, Dallas, Texas, United States Benchmark Research, Fort Worth, Texas, United States Research Your Health, Plano, Texas, United States Mt. Olympus Medical Research, LLC, Sugar Land, Texas, United States Sugar Lakes Family Practice, Sugar Land, Texas, United States DM Clinical Research/Martin Diagnostic Clinic, Tomball, Texas, United States South Ogden Family Medicine, Ogden, Utah, United States Advanced Clinical Research, Inc., West Jordan, Utah, United States Mautalen Salud e Investigacion (Expertia SA), Buenos Aires, Argentina Fundacion FunDaMos, Buenos Aires, Argentina Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich, Buenos Aires, Argentina Sanatorio Allende, Cordoba, Argentina Clinica Mayo de UMCB SRL, San Miguel De Tucuman, Argentina Instituto de Pesquisas Clinicas L2IP, Brasilia, Brazil Unidade Hospital do Rocio, Campo Largo, Brazil Santa Casa De Misericordia De Belo Horizonte, Minas Gerais, Brazil Centro de Pesquisa Clinica - Hospital Moinhos de Vento, Porto Alegre, Brazil IBPClin Instituto Brasil de Pequisa Clinica, Rio De Janeiro, Brazil Fundacao Faculdade Regional de Medicina de Sao Jose do Rio Preto, Sao Paulo, Brazil Azidus Brasil Pesquisa e Desenvolvimento Ltda, Valinhos, Brazil CARe Clinic, Red Deer, Alberta, Canada IWK Health Centre- Dalhousie University-Canadian Center for Vaccinology, Halifax, Nova Scotia, Canada Aggarwal and Associates Ltd, Brampton, Ontario, Canada Dawson Clinical Research Inc., Guelph, Ontario, Canada SKDS Research Inc., Newmarket, Ontario, Canada LMC Clinical Research Inc. (CPU), Toronto, Ontario, Canada Manna Research Toronto, Toronto, Ontario, Canada Manna Research (Quebec), Levis, Quebec, Canada Manna Research (Mirabel), Mirabel, Quebec, Canada McGill University Health Centre Vaccine Study Centre, Pierrefonds, Quebec, Canada CHU de Quebec-Universite Laval, Quebec City, Quebec, Canada Diex Research Quebec Inc., Quebec, Quebec, Canada Diex Recherche Joliette, Saint-Charles-Borromee, Quebec, Canada Q&T Research Sherbrooke Inc., Sherbrooke, Quebec, Canada Diex Recherche Sherbrooke, Sherbrooke, Quebec, Canada Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V., Aguascalientes, Mexico RM Pharma Specialists S.A. de C.V., Ciudad de Mexico, Mexico Centro para el Desarrollo de la Medicina y de Asistencia Medica Especializada S.C., Culiacan, Mexico Centro Multidisciplinario para el Desarrollo Especializado de la Investigacion Clinica en Yucatan S.C.P. (CEMDEICY S.C.P.), Merida, Mexico Integra RGH Centro de Investigacion, Clinica de Ozonoterapia RGH AC, Puebla, Mexico Sociedad de Metabolismo y Corazon S.C (SOMECO), Veracruz, Mexico Investigacion Biomedica para el Desarrollo de Farmacos, S.A. de C.V., Zapopan, Mexico NHS Grampian, Aberdeen, United Kingdom Synexus Midlands Clinical Research Centre, Birmingham, United Kingdom University Hospital Southampton NHS Foundation Trust (UHS), Bournemouth, United Kingdom Public Health Wales, Cardiff, United Kingdom Synexus Wales DRS, Cardiff, United Kingdom Mid and South Essex NHS Foundation Trust, Chelmsford, United Kingdom Synexus Lancashire DRS, Chorley, United Kingdom University Hospitals Derby and Burton, Derby, United Kingdom London North West University Healthcare NHS Trust, Harrow, United Kingdom Kings College Hospital, London, United Kingdom Synexus Manchester DRS, Manchester, United Kingdom University of York/York Teaching Hospital, York, United Kingdom |
